{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:02:36Z","timestamp":1779318156773,"version":"3.51.4"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T00:00:00Z","timestamp":1582675200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T00:00:00Z","timestamp":1582675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Supporting Project for the Foregoers of Main Disciplines of Jiangxi Province","award":["20162BCB22023"],"award-info":[{"award-number":["20162BCB22023"]}]},{"name":"\u201c5511\u201d Innovative Drivers for Talent Teams of Jiangxi Province","award":["20165BCB18018"],"award-info":[{"award-number":["20165BCB18018"]}]},{"name":"Nature Science Foundation of Jiangxi Province","award":["20181BAB205016"],"award-info":[{"award-number":["20181BAB205016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00277-020-03971-1","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T10:02:58Z","timestamp":1582711378000},"page":"703-714","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["An update to the pathogenesis for monoclonal gammopathy of renal significance"],"prefix":"10.1007","volume":"99","author":[{"given":"Chao","family":"Zuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuge","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaosi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,26]]},"reference":[{"issue":"7","key":"3971_CR1","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1681\/ASN.2017121319","volume":"29","author":"S Sethi","year":"2018","unstructured":"Sethi S, Rajkumar SV, D\u2019Agati VD (2018) The complexity and heterogeneity of monoclonal immunoglobulin-associated renal diseases. J Am Soc Nephrol 29(7):1810\u20131823. https:\/\/doi.org\/10.1681\/ASN.2017121319","journal-title":"J Am Soc Nephrol"},{"issue":"13","key":"3971_CR2","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, Dispenzieri A, Katzmann JA, Melton LJ 3rd (2006) Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 354(13):1362\u20131369. https:\/\/doi.org\/10.1056\/NEJMoa054494","journal-title":"N Engl J Med"},{"issue":"22","key":"3971_CR3","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1182\/blood-2012-07-445304","volume":"120","author":"N Leung","year":"2012","unstructured":"Leung N, Bridoux F, Hutchison CA, Nasr SH, Cockwell P, Fermand JP, Dispenzieri A, Song KW, Kyle RA, International K, Monoclonal Gammopathy Research G (2012) Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood 120(22):4292\u20134295. https:\/\/doi.org\/10.1182\/blood-2012-07-445304","journal-title":"Blood"},{"issue":"22","key":"3971_CR4","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1182\/blood-2013-05-495,929","volume":"122","author":"JP Fermand","year":"2013","unstructured":"Fermand JP, Bridoux F, Kyle RA, Kastritis E, Weiss BM, Cook MA, Drayson MT, Dispenzieri A, Leung N, International K, Monoclonal Gammopathy Research G (2013) How I treat monoclonal gammopathy of renal significance (MGRS). Blood 122(22):3583\u20133590. https:\/\/doi.org\/10.1182\/blood-2013-05-495,929","journal-title":"Blood"},{"issue":"11","key":"3971_CR5","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1182\/blood-2016-08-737,163","volume":"129","author":"S Chauvet","year":"2017","unstructured":"Chauvet S, Fremeaux-Bacchi V, Petitprez F, Karras A, Daniel L, Burtey S, Choukroun G, Delmas Y, Guerrot D, Francois A, Le Quintrec M, Javaugue V, Ribes D, Vrigneaud L, Arnulf B, Goujon JM, Ronco P, Touchard G, Bridoux F (2017) Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy. Blood 129(11):1437\u20131447. https:\/\/doi.org\/10.1182\/blood-2016-08-737,163","journal-title":"Blood"},{"issue":"1","key":"3971_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","volume":"15","author":"N Leung","year":"2019","unstructured":"Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D\u2019Agati VD, Dispenzieri A, Fervenza FC, Fermand JP, Gibbs S, Gillmore JD, Herrera GA, Jaccard A, Jevremovic D, Kastritis E, Kukreti V, Kyle RA, Lachmann HJ, Larsen CP, Ludwig H, Markowitz GS, Merlini G, Mollee P, Picken MM, Rajkumar VS, Royal V, Sanders PW, Sethi S, Venner CP, Voorhees PM, Wechalekar AD, Weiss BM, Nasr SH (2019) The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol 15(1):45\u201359. https:\/\/doi.org\/10.1038\/s41581-018-0077-4","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"3971_CR7","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.kint.2016.02.001","volume":"89","author":"SH Nasr","year":"2016","unstructured":"Nasr SH, Collins AB, Alexander MP, Schraith DF, Herrera Hernandez L, Fidler ME, Sethi S, Leung N, Fervenza FC, Cornell LD (2016) The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis. Kidney Int 89(4):897\u2013908. https:\/\/doi.org\/10.1016\/j.kint.2016.02.001","journal-title":"Kidney Int"},{"issue":"6","key":"3971_CR8","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.ekir.2017.07.008","volume":"2","author":"A Best Rocha","year":"2017","unstructured":"Best Rocha A, Larsen CP (2017) Membranous glomerulopathy with light chain-restricted deposits: a clinicopathological analysis of 28 cases. Kidney Int Rep 2(6):1141\u20131148. https:\/\/doi.org\/10.1016\/j.ekir.2017.07.008","journal-title":"Kidney Int Rep"},{"issue":"3","key":"3971_CR9","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.kint.2016.09.045","volume":"91","author":"A Ravindran","year":"2017","unstructured":"Ravindran A, Go RS, Fervenza FC, Sethi S (2017) Thrombotic microangiopathy associated with monoclonal gammopathy. Kidney Int 91(3):691\u2013698. https:\/\/doi.org\/10.1016\/j.kint.2016.09.045","journal-title":"Kidney Int"},{"issue":"11","key":"3971_CR10","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.4049\/jimmunol.1402770","volume":"194","author":"C Blanc","year":"2015","unstructured":"Blanc C, Togarsimalemath SK, Chauvet S, Le Quintrec M, Moulin B, Buchler M, Jokiranta TS, Roumenina LT, Fremeaux-Bacchi V, Dragon-Durey MA (2015) Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases. J Immunol 194(11):5129\u20135138. https:\/\/doi.org\/10.4049\/jimmunol.1402770","journal-title":"J Immunol"},{"issue":"1","key":"3971_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/ndtplus\/sfp140","volume":"3","author":"N Leung","year":"2010","unstructured":"Leung N, Buadi FK, Song KW, Magil AB, Cornell LD (2010) A case of bilateral renal arterial thrombosis associated with cryocrystalglobulinaemia. NDT Plus 3(1):74\u201377. https:\/\/doi.org\/10.1093\/ndtplus\/sfp140","journal-title":"NDT Plus"},{"issue":"1","key":"3971_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.kint.2018.01.037","volume":"94","author":"A Ravindran","year":"2018","unstructured":"Ravindran A, Fervenza FC, Smith RJH, Sethi S (2018) C3 glomerulopathy associated with monoclonal Ig is a distinct subtype. Kidney Int 94(1):178\u2013186. https:\/\/doi.org\/10.1016\/j.kint.2018.01.037","journal-title":"Kidney Int"},{"issue":"11","key":"3971_CR13","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/nrneph.2012.213","volume":"8","author":"AS Bomback","year":"2012","unstructured":"Bomback AS, Appel GB (2012) Pathogenesis of the C3 glomerulopathies and reclassification of MPGN. Nat Rev Nephrol 8(11):634\u2013642. https:\/\/doi.org\/10.1038\/nrneph.2012.213","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"3971_CR14","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ki.2012.63","volume":"82","author":"A Servais","year":"2012","unstructured":"Servais A, Noel LH, Roumenina LT, Le Quintrec M, Ngo S, Dragon-Durey MA, Macher MA, Zuber J, Karras A, Provot F, Moulin B, Grunfeld JP, Niaudet P, Lesavre P, Fremeaux-Bacchi V (2012) Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int 82(4):454\u2013464. https:\/\/doi.org\/10.1038\/ki.2012.63","journal-title":"Kidney Int"},{"issue":"9","key":"3971_CR15","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, Lambris JD (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11(9):785\u2013797. https:\/\/doi.org\/10.1038\/ni.1923","journal-title":"Nat Immunol"},{"issue":"2","key":"3971_CR16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1053\/j.ajkd.2015.03.040","volume":"66","author":"M Noris","year":"2015","unstructured":"Noris M, Remuzzi G (2015) Glomerular diseases dependent on complement activation, including atypical hemolytic uremic syndrome, membranoproliferative glomerulonephritis, and C3 glomerulopathy: core curriculum 2015. Am J Kidney Dis 66(2):359\u2013375. https:\/\/doi.org\/10.1053\/j.ajkd.2015.03.040","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"3971_CR17","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/ng912","volume":"31","author":"MC Pickering","year":"2002","unstructured":"Pickering MC, Cook HT, Warren J, Bygrave AE, Moss J, Walport MJ, Botto M (2002) Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 31(4):424\u2013428. https:\/\/doi.org\/10.1038\/ng912","journal-title":"Nat Genet"},{"key":"3971_CR18","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.3389\/fimmu.2018.02260","volume":"9","author":"S Chauvet","year":"2018","unstructured":"Chauvet S, Roumenina LT, Aucouturier P, Marinozzi MC, Dragon-Durey MA, Karras A, Delmas Y, Le Quintrec M, Guerrot D, Jourde-Chiche N, Ribes D, Ronco P, Bridoux F, Fremeaux-Bacchi V (2018) Both monoclonal and polyclonal immunoglobulin contingents mediate complement activation in monoclonal gammopathy associated-C3 glomerulopathy. Front Immunol 9:2260. https:\/\/doi.org\/10.3389\/fimmu.2018.02260","journal-title":"Front Immunol"},{"issue":"10","key":"3971_CR19","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1172\/JCI43343","volume":"120","author":"R Martinez-Barricarte","year":"2010","unstructured":"Martinez-Barricarte R, Heurich M, Valdes-Canedo F, Vazquez-Martul E, Torreira E, Montes T, Tortajada A, Pinto S, Lopez-Trascasa M, Morgan BP, Llorca O, Harris CL, Rodriguez de Cordoba S (2010) Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation. J Clin Invest 120(10):3702\u20133712. https:\/\/doi.org\/10.1172\/JCI43343","journal-title":"J Clin Invest"},{"issue":"9743","key":"3971_CR20","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/s0140-6736(10)60670-8","volume":"376","author":"DP Gale","year":"2010","unstructured":"Gale DP, de Jorge EG, Cook HT, Martinez-Barricarte R, Hadjisavvas A, McLean AG, Pusey CD, Pierides A, Kyriacou K, Athanasiou Y, Voskarides K, Deltas C, Palmer A, Fr\u00e9meaux-Bacchi V, de Cordoba SR, Maxwell PH, Pickering MC (2010) Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet 376(9743):794\u2013801. https:\/\/doi.org\/10.1016\/s0140-6736(10)60670-8","journal-title":"Lancet"},{"issue":"11","key":"3971_CR21","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1038\/ki.2008.354","volume":"75","author":"S Habbig","year":"2009","unstructured":"Habbig S, Mihatsch MJ, Heinen S, Beck B, Emmel M, Skerka C, Kirschfink M, Hoppe B, Zipfel PF, Licht C (2009) C3 deposition glomerulopathy due to a functional factor H defect. Kidney Int 75(11):1230\u20131234. https:\/\/doi.org\/10.1038\/ki.2008.354","journal-title":"Kidney Int"},{"issue":"1","key":"3971_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1681\/ASN.2012060571","volume":"24","author":"MM Ruseva","year":"2013","unstructured":"Ruseva MM, Vernon KA, Lesher AM, Schwaeble WJ, Ali YM, Botto M, Cook T, Song W, Stover CM, Pickering MC (2013) Loss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency. J Am Soc Nephrol 24(1):43\u201352. https:\/\/doi.org\/10.1681\/ASN.2012060571","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"3971_CR23","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.kint.2017.04.017","volume":"92","author":"MC Marinozzi","year":"2017","unstructured":"Marinozzi MC, Chauvet S, Le Quintrec M, Mignotet M, Petitprez F, Legendre C, Cailliez M, Deschenes G, Fischbach M, Karras A, Nobili F, Pietrement C, Dragon-Durey MA, Fakhouri F, Roumenina LT, Fremeaux-Bacchi V (2017) C5 nephritic factors drive the biological phenotype of C3 glomerulopathies. Kidney Int 92(5):1232\u20131241. https:\/\/doi.org\/10.1016\/j.kint.2017.04.017","journal-title":"Kidney Int"},{"issue":"5","key":"3971_CR24","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1053\/j.ajkd.2010.06.021","volume":"56","author":"S Sethi","year":"2010","unstructured":"Sethi S, Sukov WR, Zhang Y, Fervenza FC, Lager DJ, Miller DV, Cornell LD, Krishnan SG, Smith RJ (2010) Dense deposit disease associated with monoclonal gammopathy of undetermined significance. Am J Kidney Dis 56(5):977\u2013982. https:\/\/doi.org\/10.1053\/j.ajkd.2010.06.021","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"3971_CR25","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1053\/j.ajkd.2013.02.370","volume":"62","author":"L Zand","year":"2013","unstructured":"Zand L, Kattah A, Fervenza FC, Smith RJ, Nasr SH, Zhang Y, Vrana JA, Leung N, Cornell LD, Sethi S (2013) C3 glomerulonephritis associated with monoclonal gammopathy: a case series. Am J Kidney Dis 62(3):506\u2013514. https:\/\/doi.org\/10.1053\/j.ajkd.2013.02.370","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"3971_CR26","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1681\/ASN.2015040348","volume":"27","author":"S Chauvet","year":"2016","unstructured":"Chauvet S, Roumenina LT, Bruneau S, Marinozzi MC, Rybkine T, Schramm EC, Java A, Atkinson JP, Aldigier JC, Bridoux F, Touchard G, Fremeaux-Bacchi V (2016) A familial C3GN secondary to defective C3 regulation by complement receptor 1 and complement factor H. J Am Soc Nephrol 27(6):1665\u20131677. https:\/\/doi.org\/10.1681\/ASN.2015040348","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"3971_CR27","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10157-016-1358-5","volume":"21","author":"N Ito","year":"2017","unstructured":"Ito N, Ohashi R, Nagata M (2017) C3 glomerulopathy and current dilemmas. Clin Exp Nephrol 21(4):541\u2013551. https:\/\/doi.org\/10.1007\/s10157-016-1358-5","journal-title":"Clin Exp Nephrol"},{"issue":"11","key":"3971_CR28","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.mayocp.2013.08.002","volume":"88","author":"S Sethi","year":"2013","unstructured":"Sethi S, Rajkumar SV (2013) Monoclonal gammopathy-associated proliferative glomerulonephritis. Mayo Clin Proc 88(11):1284\u20131293. https:\/\/doi.org\/10.1016\/j.mayocp.2013.08.002","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"3971_CR29","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1182\/blood-2018-09-872028","volume":"133","author":"F Joly","year":"2019","unstructured":"Joly F, Cohen C, Javaugue V, Bender S, Belmouaz M, Arnulf B, Knebelmann B, Nouvier M, Audard V, Provot F, Gnemmi V, Nochy D, Goujon JM, Jaccard A, Touchard G, Fermand JP, Sirac C, Bridoux F (2019) Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study. Blood 133(6):576\u2013587. https:\/\/doi.org\/10.1182\/blood-2018-09-872028","journal-title":"Blood"},{"issue":"2","key":"3971_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2215\/CJN.08640811","volume":"7","author":"SH Nasr","year":"2012","unstructured":"Nasr SH, Valeri AM, Cornell LD, Fidler ME, Sethi S, D\u2019Agati VD, Leung N (2012) Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution. Clin J Am Soc Nephrol 7(2):231\u2013239. https:\/\/doi.org\/10.2215\/CJN.08640811","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"3971_CR31","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1681\/ASN.V1271482","volume":"12","author":"J Lin","year":"2001","unstructured":"Lin J, Markowitz GS, Valeri AM, Kambham N, Sherman WH, Appel GB, D\u2019Agati VD (2001) Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol 12(7):1482\u20131492","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"3971_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.7326\/0003-4819-76-3-112-6-455","volume":"112","author":"JN Buxbaum","year":"1990","unstructured":"Buxbaum JN, Chuba JV, Hellman GC, Solomon A, Gallo GR (1990) Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis. Ann Intern Med 112(6):455\u2013464","journal-title":"Ann Intern Med"},{"issue":"2","key":"3971_CR33","first-page":"150","volume":"3","author":"R Confalonieri","year":"1988","unstructured":"Confalonieri R, Barbiano di Belgiojoso G, Banfi G, Ferrario F, Bertani T, Pozzi C, Casanova S, Lupo A, De Ferrari G, Minetti L (1988) Light chain nephropathy: histological and clinical aspects in 15 cases. Nephrol Dial Transplant 3(2):150\u2013156","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"3971_CR34","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1172\/JCI115252","volume":"87","author":"M Cogne","year":"1991","unstructured":"Cogne M, Preud\u2019homme JL, Bauwens M, Touchard G, Aucouturier P (1991) Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease. J Clin Invest 87(6):2186\u20132190. https:\/\/doi.org\/10.1172\/JCI115252","journal-title":"J Clin Invest"},{"issue":"1\u20132","key":"3971_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0165-2478(94)90036-1","volume":"42","author":"L Denoroy","year":"1994","unstructured":"Denoroy L, Deret S, Aucouturier P (1994) Overrepresentation of the V kappa IV subgroup in light chain deposition disease. Immunol Lett 42(1\u20132):63\u201366","journal-title":"Immunol Lett"},{"issue":"10","key":"3971_CR36","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/protein\/10.10.1191","volume":"10","author":"S Deret","year":"1997","unstructured":"Deret S, Chomilier J, Huang DB, Preud\u2019homme JL, Stevens FJ, Aucouturier P (1997) Molecular modeling of immunoglobulin light chains implicates hydrophobic residues in non-amyloid light chain deposition disease. Protein Eng 10(10):1191\u20131197","journal-title":"Protein Eng"},{"issue":"5","key":"3971_CR37","first-page":"1397","volume":"148","author":"G Gallo","year":"1996","unstructured":"Gallo G, Goni F, Boctor F, Vidal R, Kumar A, Stevens FJ, Frangione B, Ghiso J (1996) Light chain cardiomyopathy. Structural analysis of the light chain tissue deposits. Am J Pathol 148(5):1397\u20131406","journal-title":"Am J Pathol"},{"issue":"4","key":"3971_CR38","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/labinvest.3700069","volume":"84","author":"J Teng","year":"2004","unstructured":"Teng J, Russell WJ, Gu X, Cardelli J, Jones ML, Herrera GA (2004) Different types of glomerulopathic light chains interact with mesangial cells using a common receptor but exhibit different intracellular trafficking patterns. Lab Investig 84(4):440\u2013451. https:\/\/doi.org\/10.1038\/labinvest.3700069","journal-title":"Lab Investig"},{"issue":"1","key":"3971_CR39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12967-019-02147-4","volume":"17","author":"Q Wang","year":"2019","unstructured":"Wang Q, Jiang F, Xu G (2019) The pathogenesis of renal injury and treatment in light chain deposition disease. J Transl Med 17(1):387\u2013387. https:\/\/doi.org\/10.1186\/s12967-019-02147-4","journal-title":"J Transl Med"},{"issue":"12","key":"3971_CR40","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/ki.2011.94","volume":"79","author":"K Basnayake","year":"2011","unstructured":"Basnayake K, Stringer SJ, Hutchison CA, Cockwell P (2011) The biology of immunoglobulin free light chains and kidney injury. Kidney Int 79(12):1289\u20131301. https:\/\/doi.org\/10.1038\/ki.2011.94","journal-title":"Kidney Int"},{"issue":"5","key":"3971_CR41","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/labinvest.3780278","volume":"81","author":"WJ Russell","year":"2001","unstructured":"Russell WJ, Cardelli J, Harris E, Baier RJ, Herrera GA (2001) Monoclonal light chain--mesangial cell interactions: early signaling events and subsequent pathologic effects. Lab Investig 81(5):689\u2013703","journal-title":"Lab Investig"},{"issue":"7","key":"3971_CR42","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.4049\/jimmunol.159.7.3474","volume":"159","author":"N Duque","year":"1997","unstructured":"Duque N, Gomez-Guerrero C, Egido J (1997) Interaction of IgA with fc alpha receptors of human mesangial cells activates transcription factor nuclear factor-kappa B and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and IFN-inducible protein 10. J Immunol 159(7):3474\u20133482","journal-title":"J Immunol"},{"issue":"6","key":"3971_CR43","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/ki.2008.504","volume":"75","author":"J Keeling","year":"2009","unstructured":"Keeling J, Herrera GA (2009) An in vitro model of light chain deposition disease. Kidney Int 75(6):634\u2013645. https:\/\/doi.org\/10.1038\/ki.2008.504","journal-title":"Kidney Int"},{"issue":"4","key":"3971_CR44","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3109\/13506129809007296","volume":"5","author":"J Isaac","year":"1998","unstructured":"Isaac J, Kerby JD, Russell WJ, Dempsey SC, Sanders PW, Herrera GA (1998) In vitro modulation of AL-amyloid formation by human mesangial cells exposed to amyloidogenic light chains. Amyloid 5(4):238\u2013246","journal-title":"Amyloid"},{"issue":"2","key":"3971_CR45","first-page":"375","volume":"147","author":"L Zhu","year":"1995","unstructured":"Zhu L, Herrera GA, Murphy-Ullrich JE, Huang ZQ, Sanders PW (1995) Pathogenesis of glomerulosclerosis in light chain deposition disease. Role for transforming growth factor-beta. Am J Pathol 147(2):375\u2013385","journal-title":"Am J Pathol"},{"issue":"2","key":"3971_CR46","doi-asserted-by":"publisher","first-page":"p28","DOI":"10.1159\/000071288","volume":"94","author":"J Teng","year":"2003","unstructured":"Teng J, Zhang PL, Russell WJ, Zheng LP, Jones ML, Herrera GA (2003) Insights into mechanisms responsible for mesangial alterations associated with fibrogenic glomerulopathic light chains. Nephron Physiol 94(2):p28\u2013p38. https:\/\/doi.org\/10.1159\/000071288","journal-title":"Nephron Physiol"},{"issue":"4","key":"3971_CR47","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1111\/j.1523-1755.2005.00571.x","volume":"68","author":"J Keeling","year":"2005","unstructured":"Keeling J, Herrera GA (2005) Matrix metalloproteinases and mesangial remodeling in light chain-related glomerular damage. Kidney Int 68(4):1590\u20131603. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00571.x","journal-title":"Kidney Int"},{"issue":"10","key":"3971_CR48","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/labinvest.3700161","volume":"84","author":"J Keeling","year":"2004","unstructured":"Keeling J, Teng J, Herrera GA (2004) AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells. Lab Investig 84(10):1322\u20131338. https:\/\/doi.org\/10.1038\/labinvest.3700161","journal-title":"Lab Investig"},{"issue":"1","key":"3971_CR49","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.1053\/j.ajkd.2003.09.024","volume":"43","author":"J Soma","year":"2004","unstructured":"Soma J, Sato K, Sakuma T, Saito H, Sato H, Sato T, Abbas A, Aucouturier P (2004) Immunoglobulin gamma3-heavy-chain deposition disease: report of a case and relationship with hypocomplementemia. Am J Kidney Dis 43(1):E10\u2013E16","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"3971_CR50","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.kint.2016.09.004","volume":"91","author":"F Bridoux","year":"2017","unstructured":"Bridoux F, Javaugue V, Bender S, Leroy F, Aucouturier P, Debiais-Delpech C, Goujon JM, Quellard N, Bonaud A, Clavel M, Trouillas P, Di Meo F, Gombert JM, Fermand JP, Jaccard A, Cogne M, Touchard G, Sirac C (2017) Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management. Kidney Int 91(2):423\u2013434. https:\/\/doi.org\/10.1016\/j.kint.2016.09.004","journal-title":"Kidney Int"},{"issue":"2","key":"3971_CR51","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0272-6386(96)90315-7","volume":"28","author":"IK Cheng","year":"1996","unstructured":"Cheng IK, Ho SK, Chan DT, Ng WK, Chan KW (1996) Crescentic nodular glomerulosclerosis secondary to truncated immunoglobulin alpha heavy chain deposition. Am J Kidney Dis 28(2):283\u2013288","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"3971_CR52","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1083\/jcb.104.3.761","volume":"104","author":"L Hendershot","year":"1987","unstructured":"Hendershot L, Bole D, Kohler G, Kearney JF (1987) Assembly and secretion of heavy chains that do not associate posttranslationally with immunoglobulin heavy chain-binding protein. J Cell Biol 104(3):761\u2013767","journal-title":"J Cell Biol"},{"issue":"6","key":"3971_CR53","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1182\/blood-2015-03-630277","volume":"126","author":"A Bonaud","year":"2015","unstructured":"Bonaud A, Bender S, Touchard G, Lacombe C, Srour N, Delpy L, Oblet C, Druilhe A, Quellard N, Javaugue V, Cogne M, Bridoux F, Sirac C (2015) A mouse model recapitulating human monoclonal heavy chain deposition disease evidences the relevance of proteasome inhibitor therapy. Blood 126(6):757\u2013765. https:\/\/doi.org\/10.1182\/blood-2015-03-630277","journal-title":"Blood"},{"issue":"4","key":"3971_CR54","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/ki.1994.355","volume":"46","author":"JL Preud\u2019homme","year":"1994","unstructured":"Preud\u2019homme JL, Aucouturier P, Touchard G, Striker L, Khamlichi AA, Rocca A, Denoroy L, Cogne M (1994) Monoclonal immunoglobulin deposition disease (Randall type). Relationship with structural abnormalities of immunoglobulin chains. Kidney Int 46(4):965\u2013972","journal-title":"Kidney Int"},{"issue":"5","key":"3971_CR55","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1365-2141.2006.06488.x","volume":"136","author":"B Kaplan","year":"2007","unstructured":"Kaplan B, Livneh A, Gallo G (2007) Charge differences between in vivo deposits in immunoglobulin light chain amyloidosis and non-amyloid light chain deposition disease. Br J Haematol 136(5):723\u2013728. https:\/\/doi.org\/10.1111\/j.1365-2141.2006.06488.x","journal-title":"Br J Haematol"},{"issue":"11","key":"3971_CR56","doi-asserted-by":"publisher","first-page":"e557","DOI":"10.3324\/haematol.2018.196113","volume":"103","author":"S Bender","year":"2018","unstructured":"Bender S, Ayala MV, Javaugue V, Bonaud A, Cogne M, Touchard G, Jaccard A, Bridoux F, Sirac C (2018) Comprehensive molecular characterization of a heavy chain deposition disease case. Haematologica 103(11):e557\u2013e560. https:\/\/doi.org\/10.3324\/haematol.2018.196113","journal-title":"Haematologica"},{"issue":"9","key":"3971_CR57","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.2215\/CJN.10491012","volume":"8","author":"SM Said","year":"2013","unstructured":"Said SM, Sethi S, Valeri AM, Leung N, Cornell LD, Fidler ME, Herrera Hernandez L, Vrana JA, Theis JD, Quint PS, Dogan A, Nasr SH (2013) Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases. Clin J Am Soc Nephrol 8(9):1515\u20131523. https:\/\/doi.org\/10.2215\/CJN.10491012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"3971_CR58","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJMra023144","volume":"349","author":"G Merlini","year":"2003","unstructured":"Merlini G, Bellotti V (2003) Molecular mechanisms of amyloidosis. N Engl J Med 349(6):583\u2013596. https:\/\/doi.org\/10.1056\/NEJMra023144","journal-title":"N Engl J Med"},{"issue":"12","key":"3971_CR59","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1681\/ASN.2006050460","volume":"17","author":"LM Dember","year":"2006","unstructured":"Dember LM (2006) Amyloidosis-associated kidney disease. J Am Soc Nephrol 17(12):3458\u20133471. https:\/\/doi.org\/10.1681\/ASN.2006050460","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"3971_CR60","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1073\/pnas.92.10.4299","volume":"92","author":"GA Tennent","year":"1995","unstructured":"Tennent GA, Lovat LB, Pepys MB (1995) Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc Natl Acad Sci U S A 92(10):4299\u20134303","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3971_CR61","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","volume":"57","author":"JC Brouet","year":"1974","unstructured":"Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M (1974) Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 57(5):775\u2013788","journal-title":"Am J Med"},{"issue":"4","key":"3971_CR62","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/00005792-200107000-00004","volume":"80","author":"O Trejo","year":"2001","unstructured":"Trejo O, Ramos-Casals M, Garcia-Carrasco M, Yague J, Jimenez S, de la Red G, Cervera R, Font J, Ingelmo M (2001) Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) 80(4):252\u2013262","journal-title":"Medicine (Baltimore)"},{"issue":"9813","key":"3971_CR63","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/s0140-6736(11)60242-0","volume":"379","author":"M Ramos-Casals","year":"2012","unstructured":"Ramos-Casals M, Stone JH, Cid MC, Bosch X (2012) The cryoglobulinaemias. Lancet 379(9813):348\u2013360. https:\/\/doi.org\/10.1016\/s0140-6736(11)60242-0","journal-title":"Lancet"},{"issue":"1","key":"3971_CR64","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.autrev.2004.04.004","volume":"4","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals M, De Vita S, Tzioufas AG (2005) Hepatitis C virus, Sjogren\u2019s syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. Autoimmun Rev 4(1):8\u201315. https:\/\/doi.org\/10.1016\/j.autrev.2004.04.004","journal-title":"Autoimmun Rev"},{"issue":"1","key":"3971_CR65","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/oxfordjournals.jbchem.a134592","volume":"95","author":"Y Nishimura","year":"1984","unstructured":"Nishimura Y, Nakamura H (1984) Human monoclonal cryoimmunoglobulins. I. Molecular properties of IgG3 kappa (Jir protein) and the cryo-coprecipitability of its molecular fragments by papain. J Biochem 95(1):255\u2013265. https:\/\/doi.org\/10.1093\/oxfordjournals.jbchem.a134592","journal-title":"J Biochem"},{"issue":"2","key":"3971_CR66","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/eji.1830190209","volume":"19","author":"F Spertini","year":"1989","unstructured":"Spertini F, Coulie PG, Van Snick J, Davidson E, Lambert PH, Izui S (1989) Inhibition of cryoprecipitation of murine IgG3 anti-dinitrophenyl (DNP) monoclonal antibodies by anionic DNP-amino acid conjugates. Eur J Immunol 19(2):273\u2013278. https:\/\/doi.org\/10.1002\/eji.1830190209","journal-title":"Eur J Immunol"},{"issue":"2","key":"3971_CR67","first-page":"340","volume":"55","author":"J Strevey","year":"1984","unstructured":"Strevey J, Beaulieu AD, Menard C, Valet JP, Latulippe L, Hebert J (1984) The role of fibronectin in the cryoprecipitation of monoclonal cryoglobulins. Clin Exp Immunol 55(2):340\u2013346","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"3971_CR68","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1681\/ASN.2012050477","volume":"23","author":"M Otani","year":"2012","unstructured":"Otani M, Kuroki A, Kikuchi S, Kihara M, Nakata J, Ito K, Furukawa J, Shinohara Y, Izui S (2012) Sialylation determines the nephritogenicity of IgG3 cryoglobulins. J Am Soc Nephrol 23(11):1869\u20131878. https:\/\/doi.org\/10.1681\/ASN.2012050477","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"3971_CR69","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.4049\/jimmunol.175.2.1056","volume":"175","author":"Y Kuroda","year":"2005","unstructured":"Kuroda Y, Kuroki A, Kikuchi S, Funase T, Nakata M, Izui S (2005) A critical role for sialylation in cryoglobulin activity of murine IgG3 monoclonal antibodies. J Immunol 175(2):1056\u20131061. https:\/\/doi.org\/10.4049\/jimmunol.175.2.1056","journal-title":"J Immunol"},{"issue":"11","key":"3971_CR70","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1681\/ASN.2012040388","volume":"23","author":"PW Sanders","year":"2012","unstructured":"Sanders PW (2012) Mechanisms of light chain injury along the tubular nephron. J Am Soc Nephrol 23(11):1777\u20131781. https:\/\/doi.org\/10.1681\/ASN.2012040388","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"3971_CR71","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1681\/ASN.2015020185","volume":"27","author":"MB Stokes","year":"2016","unstructured":"Stokes MB, Valeri AM, Herlitz L, Khan AM, Siegel DS, Markowitz GS, D\u2019Agati VD (2016) Light chain proximal tubulopathy: clinical and pathologic characteristics in the modern treatment era. J Am Soc Nephrol 27(5):1555\u20131565. https:\/\/doi.org\/10.1681\/ASN.2015020185","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"3971_CR72","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1182\/blood-2005-11-4419","volume":"108","author":"C Sirac","year":"2006","unstructured":"Sirac C, Bridoux F, Carrion C, Devuyst O, Fernandez B, Goujon JM, El Hamel C, Aldigier JC, Touchard G, Cogne M (2006) Role of the monoclonal kappa chain V domain and reversibility of renal damage in a transgenic model of acquired Fanconi syndrome. Blood 108(2):536\u2013543. https:\/\/doi.org\/10.1182\/blood-2005-11-4419","journal-title":"Blood"},{"issue":"7","key":"3971_CR73","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/ki.2008.666","volume":"76","author":"LC Herlitz","year":"2009","unstructured":"Herlitz LC, Roglieri J, Resta R, Bhagat G, Markowitz GS (2009) Light chain proximal tubulopathy. Kidney Int 76(7):792\u2013797. https:\/\/doi.org\/10.1038\/ki.2008.666","journal-title":"Kidney Int"},{"issue":"4","key":"3971_CR74","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1681\/ASN.2006111299","volume":"18","author":"PX Wang","year":"2007","unstructured":"Wang PX, Sanders PW (2007) Immunoglobulin light chains generate hydrogen peroxide. J Am Soc Nephrol 18(4):1239\u20131245. https:\/\/doi.org\/10.1681\/ASN.2006111299","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"3971_CR75","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1681\/ASN.2009101089","volume":"21","author":"K Basnayake","year":"2010","unstructured":"Basnayake K, Ying WZ, Wang PX, Sanders PW (2010) Immunoglobulin light chains activate tubular epithelial cells through redox signaling. J Am Soc Nephrol 21(7):1165\u20131173. https:\/\/doi.org\/10.1681\/ASN.2009101089","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"3971_CR76","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1182\/blood-2010-08-302505","volume":"117","author":"WZ Ying","year":"2011","unstructured":"Ying WZ, Wang PX, Aaron KJ, Basnayake K, Sanders PW (2011) Immunoglobulin light chains activate nuclear factor-kappaB in renal epithelial cells through a Src-dependent mechanism. Blood 117(4):1301\u20131307. https:\/\/doi.org\/10.1182\/blood-2010-08-302505","journal-title":"Blood"},{"key":"3971_CR77","doi-asserted-by":"publisher","unstructured":"Ying WZ, Li X, Rangarajan S, Feng W, Curtis LM, Sanders PW (2019) Immunoglobulin light chains generate pro-inflammatory and pro-fibrotic kidney injury. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI125517","DOI":"10.1172\/JCI125517"},{"issue":"11","key":"3971_CR78","doi-asserted-by":"publisher","first-page":"F1263","DOI":"10.1152\/ajprenal.00211.2014","volume":"307","author":"FY Ma","year":"2014","unstructured":"Ma FY, Tesch GH, Nikolic-Paterson DJ (2014) ASK1\/p38 signaling in renal tubular epithelial cells promotes renal fibrosis in the mouse obstructed kidney. Am J Physiol Ren Physiol 307(11):F1263\u2013F1273. https:\/\/doi.org\/10.1152\/ajprenal.00211.2014","journal-title":"Am J Physiol Ren Physiol"},{"issue":"1","key":"3971_CR79","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ajpath.2011.09.017","volume":"180","author":"WZ Ying","year":"2012","unstructured":"Ying WZ, Wang PX, Sanders PW (2012) Pivotal role of apoptosis signal-regulating kinase 1 in monoclonal free light chain-mediated apoptosis. Am J Pathol 180(1):41\u201347. https:\/\/doi.org\/10.1016\/j.ajpath.2011.09.017","journal-title":"Am J Pathol"},{"issue":"7","key":"3971_CR80","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1681\/ASN.2015050581","volume":"27","author":"A Luciani","year":"2016","unstructured":"Luciani A, Sirac C, Terryn S, Javaugue V, Prange JA, Bender S, Bonaud A, Cogne M, Aucouturier P, Ronco P, Bridoux F, Devuyst O (2016) Impaired lysosomal function underlies monoclonal light chain-associated renal Fanconi syndrome. J Am Soc Nephrol 27(7):2049\u20132061. https:\/\/doi.org\/10.1681\/ASN.2015050581","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"3971_CR81","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1046\/j.1523-1755.2003.00853.x","volume":"63","author":"JL Rosenstock","year":"2003","unstructured":"Rosenstock JL, Markowitz GS, Valeri AM, Sacchi G, Appel GB, D\u2019Agati VD (2003) Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features. Kidney Int 63(4):1450\u20131461. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00853.x","journal-title":"Kidney Int"},{"issue":"1","key":"3971_CR82","first-page":"103","volume":"11","author":"P Grove","year":"1998","unstructured":"Grove P, Neale PH, Peck M, Schiller B, Haas M (1998) Monoclonal immunoglobulin G1-kappa fibrillary glomerulonephritis. Mod Pathol 11(1):103\u2013109","journal-title":"Mod Pathol"},{"issue":"1","key":"3971_CR83","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ekir.2017.07.017","volume":"3","author":"SH Nasr","year":"2018","unstructured":"Nasr SH, Vrana JA, Dasari S, Bridoux F, Fidler ME, Kaaki S, Quellard N, Rinsant A, Goujon JM, Sethi S, Fervenza FC, Cornell LD, Said SM, McPhail ED, Herrera Hernandez LP, Grande JP, Hogan MC, Lieske JC, Leung N, Kurtin PJ, Alexander MP (2018) DNAJB9 is a specific immunohistochemical marker for fibrillary glomerulonephritis. Kidney Int Rep 3(1):56\u201364. https:\/\/doi.org\/10.1016\/j.ekir.2017.07.017","journal-title":"Kidney Int Rep"},{"issue":"3","key":"3971_CR84","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1053\/j.ajkd.2018.03.017","volume":"72","author":"MP Alexander","year":"2018","unstructured":"Alexander MP, Dasari S, Vrana JA, Riopel J, Valeri AM, Markowitz GS, Hever A, Bijol V, Larsen CP, Cornell LD, Fidler ME, Said SM, Sethi S, Herrera Hernandez LP, Grande JP, Erickson SB, Fervenza FC, Leung N, Kurtin PJ, Nasr SH (2018) Congophilic fibrillary glomerulonephritis: a case series. Am J Kidney Dis 72(3):325\u2013336. https:\/\/doi.org\/10.1053\/j.ajkd.2018.03.017","journal-title":"Am J Kidney Dis"},{"issue":"9\u201310","key":"3971_CR85","first-page":"315","volume":"133","author":"K Galesic","year":"2011","unstructured":"Galesic K, Horvatic I, Tisljar M, Bulimbasic S, Bozic B, Ljubanovic DG (2011) Fibrillary glomerulonephritis and immunotactoid glomerulopathy: case reports. Lijec Vjesn 133(9\u201310):315\u2013319","journal-title":"Lijec Vjesn"},{"issue":"6","key":"3971_CR86","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2215\/CJN.07030712","volume":"8","author":"S Sethi","year":"2013","unstructured":"Sethi S, Theis JD, Vrana JA, Fervenza FC, Sethi A, Qian Q, Quint P, Leung N, Dogan A, Nasr SH (2013) Laser microdissection and proteomic analysis of amyloidosis, cryoglobulinemic GN, fibrillary GN, and immunotactoid glomerulopathy. Clin J Am Soc Nephrol 8(6):915\u2013921. https:\/\/doi.org\/10.2215\/CJN.07030712","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"3971_CR87","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1681\/ASN.2007070757","volume":"19","author":"CE Alpers","year":"2008","unstructured":"Alpers CE, Kowalewska J (2008) Fibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol 19(1):34\u201337. https:\/\/doi.org\/10.1681\/ASN.2007070757","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"3971_CR88","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3109\/01913123.2015.1017070","volume":"39","author":"GA Herrera","year":"2015","unstructured":"Herrera GA, Ojemakinde KO, Turbat-Herrera EA, Gu X, Zeng X, Iskandar SS (2015) Immunotactoid glomerulopathy and cryoglobulinemic nephropathy: two entities with many similarities. A unified conceptual approach. Ultrastruct Pathol 39(4):270\u2013280","journal-title":"Ultrastruct Pathol"},{"issue":"6","key":"3971_CR89","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3343\/kjlm.2010.30.6.580","volume":"30","author":"SH Park","year":"2010","unstructured":"Park SH, Ahn JY, Seo YH, Park PH, Kim KH, Song YH, Jeong JH, Lee JH (2010) A case of non-secretory myeloma with crystal-storing histiocytosis. The Korean journal of laboratory medicine 30(6):580\u2013584. https:\/\/doi.org\/10.3343\/kjlm.2010.30.6.580","journal-title":"The Korean journal of laboratory medicine"},{"issue":"2","key":"3971_CR90","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/ajcp\/aqx150","volume":"149","author":"H Fang","year":"2018","unstructured":"Fang H, Chiu A, Reichard KK (2018) Crystal-storing histiocytosis in bone marrow: a clinicopathologic study of eight cases and review of the literature. Am J Clin Pathol 149(2):148\u2013163. https:\/\/doi.org\/10.1093\/ajcp\/aqx150","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"3971_CR91","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1093\/ndt\/gfq129","volume":"25","author":"C El Hamel","year":"2010","unstructured":"El Hamel C, Thierry A, Trouillas P, Bridoux F, Carrion C, Quellard N, Goujon JM, Aldigier JC, Gombert JM, Cogne M, Touchard G (2010) Crystal-storing histiocytosis with renal Fanconi syndrome: pathological and molecular characteristics compared with classical myeloma-associated Fanconi syndrome. Nephrol Dial Transplant 25(9):2982\u20132990. https:\/\/doi.org\/10.1093\/ndt\/gfq129","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"3971_CR92","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12105-011-0326-3","volume":"6","author":"S Dogan","year":"2012","unstructured":"Dogan S, Barnes L, Cruz-Vetrano WP (2012) Crystal-storing histiocytosis: report of a case, review of the literature (80 cases) and a proposed classification. Head Neck Pathol 6(1):111\u2013120. https:\/\/doi.org\/10.1007\/s12105-011-0326-3","journal-title":"Head Neck Pathol"},{"issue":"1","key":"3971_CR93","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/00000478-200001000-00016","volume":"24","author":"S Sukpanichnant","year":"2000","unstructured":"Sukpanichnant S, Hargrove NS, Kachintorn U, Manatsathit S, Chanchairujira T, Siritanaratkul N, Akaraviputh T, Thakerngpol K (2000) Clofazimine-induced crystal-storing histiocytosis producing chronic abdominal pain in a leprosy patient. Am J Surg Pathol 24(1):129\u2013135","journal-title":"Am J Surg Pathol"},{"key":"3971_CR94","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s13730-019-00385-5","volume":"8","author":"F Galeano-Valle","year":"2019","unstructured":"Galeano-Valle F, Diaz-Crespo FJ, Melero-Martin R, Apaza-Chavez JE, Del-Toro-Cervera J, Demelo-Rodriguez P (2019) Massive generalized crystal-storing histiocytosis associated with extracellular crystalline nephropathy: clinical, immunohistochemical, and ultrastructural studies of a unique disorder and review of the literature. CEN Case Rep 8:166\u2013172. https:\/\/doi.org\/10.1007\/s13730-019-00385-5","journal-title":"CEN Case Rep"},{"issue":"14","key":"3971_CR95","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1182\/blood-2017-07-794230","volume":"130","author":"JP Balakrishna","year":"2017","unstructured":"Balakrishna JP, Jaffe ES (2017) Crystal-storing histiocytosis associated with thymic extranodal marginal zone lymphoma. Blood 130(14):1683. https:\/\/doi.org\/10.1182\/blood-2017-07-794230","journal-title":"Blood"},{"issue":"5","key":"3971_CR96","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1182\/blood.V100.5.1817.h81702001817_1817_1827","volume":"100","author":"A Lebeau","year":"2002","unstructured":"Lebeau A, Zeindl-Eberhart E, Muller EC, Muller-Hocker J, Jungblut PR, Emmerich B, Lohrs U (2002) Generalized crystal-storing histiocytosis associated with monoclonal gammopathy: molecular analysis of a disorder with rapid clinical course and review of the literature. Blood 100(5):1817\u20131827","journal-title":"Blood"},{"issue":"5","key":"3971_CR97","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.humpath.2012.10.012","volume":"44","author":"A Duquesne","year":"2013","unstructured":"Duquesne A, Werbrouck A, Fabiani B, Denoyer A, Cervera P, Verpont MC, Bender S, Piedagnel R, Brocheriou I, Ronco P, Boffa JJ, Aucouturier P, Garderet L (2013) Complete remission of monoclonal gammopathy with ocular and periorbital crystal storing histiocytosis and Fanconi syndrome. Hum Pathol 44(5):927\u2013933. https:\/\/doi.org\/10.1016\/j.humpath.2012.10.012","journal-title":"Hum Pathol"},{"issue":"9","key":"3971_CR98","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1681\/ASN.2009010110","volume":"20","author":"SH Nasr","year":"2009","unstructured":"Nasr SH, Satoskar A, Markowitz GS, Valeri AM, Appel GB, Stokes MB, Nadasdy T, D\u2019Agati VD (2009) Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol 20(9):2055\u20132064. https:\/\/doi.org\/10.1681\/ASN.2009010110","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"3971_CR99","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s13730-018-0351-0","volume":"7","author":"A Mii","year":"2018","unstructured":"Mii A, Shimizu A, Takada D, Tsuruoka S (2018) Proliferative glomerulonephritis with unusual microlamellar organized deposits related to monoclonal immunoglobulin G3 (IgG3) kappa. CEN Case Rep 7(2):320\u2013324. https:\/\/doi.org\/10.1007\/s13730-018-0351-0","journal-title":"CEN Case Rep"},{"issue":"4","key":"3971_CR100","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1053\/j.ajkd.2015.08.032","volume":"67","author":"J Hemminger","year":"2016","unstructured":"Hemminger J, Kandarpa M, Tsai A, Nadasdy T (2016) Proliferative glomerulonephritis with monoclonal IgG1kappa deposits in a hepatitis C virus-positive patient. Am J Kidney Dis 67(4):703\u2013708. https:\/\/doi.org\/10.1053\/j.ajkd.2015.08.032","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"3971_CR101","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4103\/1319-2442.202761","volume":"28","author":"N Raveendran","year":"2017","unstructured":"Raveendran N, Beniwal P, D\u2019Souza AV, Tanwar RS, Kimmatkar P, Agarwal D, Malhotra V (2017) Profile of glomerular diseases associated with hepatitis B and C: a single-center experience from India. Saudi J Kidney Dis Transpl 28(2):355\u2013361. https:\/\/doi.org\/10.4103\/1319-2442.202761","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"Suppl 1","key":"3971_CR102","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.2215\/CJN.01060307","volume":"2","author":"M Waldman","year":"2007","unstructured":"Waldman M, Kopp JB (2007) Parvovirus B19 and the kidney. Clin J Am Soc Nephrol 2(Suppl 1):S47\u2013S56. https:\/\/doi.org\/10.2215\/CJN.01060307","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"3971_CR103","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1016\/j.humpath.2012.04.004","volume":"43","author":"E Fujita","year":"2012","unstructured":"Fujita E, Shimizu A, Kaneko T, Masuda Y, Ishihara C, Mii A, Higo S, Kajimoto Y, Kanzaki G, Nagasaka S, Iino Y, Katayama Y, Fukuda Y (2012) Proliferative glomerulonephritis with monoclonal immunoglobulin G3kappa deposits in association with parvovirus B19 infection. Hum Pathol 43(12):2326\u20132333. https:\/\/doi.org\/10.1016\/j.humpath.2012.04.004","journal-title":"Hum Pathol"},{"issue":"12","key":"3971_CR104","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.2215\/CJN.02960316","volume":"11","author":"MA Perazella","year":"2016","unstructured":"Perazella MA, Finkel KW, American Society of Nephrology Onco-Nephology F (2016) Paraprotein-related kidney disease: attack of the killer M proteins. Clin J Am Soc Nephrol 11(12):2256\u20132259. https:\/\/doi.org\/10.2215\/CJN.02960316","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"3971_CR105","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s13730-013-0064-3","volume":"2","author":"R Ohashi","year":"2013","unstructured":"Ohashi R, Sakai Y, Otsuka T, Ohno D, Masuda Y, Murasawa T, Sato N, Shimizu A (2013) Proliferative glomerulonephritis with monoclonal IgG2kappa deposit successfully treated with steroids: a case report and review of the literature. CEN Case Rep 2(2):197\u2013203. https:\/\/doi.org\/10.1007\/s13730-013-0064-3","journal-title":"CEN Case Rep"},{"key":"3971_CR106","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s13730-019-00384-6","volume":"8","author":"T Katsuno","year":"2019","unstructured":"Katsuno T, Kato M, Fujita T, Tsuboi N, Hattori R, Ito Y, Maruyama S (2019) Chronological change of renal pathological findings in the proliferative glomerulonephritis with monoclonal IgG deposits considered to have recurred early after kidney transplantation. CEN Case Rep 8:151\u2013158. https:\/\/doi.org\/10.1007\/s13730-019-00384-6","journal-title":"CEN Case Rep"},{"issue":"1","key":"3971_CR107","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2215\/CJN.05750710","volume":"6","author":"SH Nasr","year":"2011","unstructured":"Nasr SH, Sethi S, Cornell LD, Fidler ME, Boelkins M, Fervenza FC, Cosio FG, D\u2019Agati VD (2011) Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft. Clin J Am Soc Nephrol 6(1):122\u2013132. https:\/\/doi.org\/10.2215\/CJN.05750710","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-03971-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-020-03971-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-03971-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T17:40:22Z","timestamp":1695836422000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-020-03971-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,26]]},"references-count":107,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["3971"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-03971-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,26]]},"assertion":[{"value":"25 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}